These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 25832710)

  • 1. Erratum to: Wallner PE, Anscher MS, Barker CA, et al. Current status and recommendations for the future of research, teaching, and testing in the biological sciences of radiation oncology: report of the American Society for Radiation Oncology Cancer Biology/Radiation Biology Task Force, executive summary. Int J Radiat Oncol Biol Phys 2014;88:11-17.
    Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):1115. PubMed ID: 25832710
    [No Abstract]   [Full Text] [Related]  

  • 2. Determination of TGF-beta1 plasma levels: In regard to Anscher et al. (Int J Radiat Oncol Biol Phys 2003;56: 988-995) and de Jaeger et al (Int J Radiat Oncol Biol Phys 2004;58: 1378-1387).
    Barthelemy-Brichant N
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1339; author reply 1339-40. PubMed ID: 15519811
    [No Abstract]   [Full Text] [Related]  

  • 3. Erratum for Dominello MM, Sanders T, Anscher M, et al. "Responses to the 2018 and 2019 "One Big Discovery" Question: ASTRO Membership's Opinions on the Most Important Research Question Facing Radiation Oncology…Where Are We Headed?" Int J Radiat Oncol Biol Phys 2021;109:38-40.
    Int J Radiat Oncol Biol Phys; 2023 Jun; 116(2):471. PubMed ID: 37179101
    [No Abstract]   [Full Text] [Related]  

  • 4. Erratum to: Fung CY, Chen E, Vapiwala N, et al. The American Society for Radiation Oncology 2017 Radiation Oncologist Workforce Study. Int J Radiat Oncol Biol Phys 2019;103:547-556.
    Int J Radiat Oncol Biol Phys; 2019 May; 104(1):226. PubMed ID: 30967235
    [No Abstract]   [Full Text] [Related]  

  • 5. Small molecular inhibitor of transforming growth factor-beta protects against development of radiation-induced lung injury. In regard to Anscher MS et al. (Int J Radiat Oncol Biol Phys 2008;71:1-9).
    Bahl A; Sharma DN; Rath GK; Julka PK
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):630. PubMed ID: 18793971
    [No Abstract]   [Full Text] [Related]  

  • 6. Lung V20 measurements: In regard to Seppenwoolde et al. (Int J Radiat Oncol Biol Phys 2003;55:724-735), and Tsujino et al. (Int J Radiat Oncol Biol Phys 2003;56:1208-1209).
    Garces YI; Miller RC
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1636; author reply 1636-7. PubMed ID: 15050346
    [No Abstract]   [Full Text] [Related]  

  • 7. Radiotherapy in pleural malignant mesothelioma: why not! In regard to Scorsetti et al. (Int J Radiat Oncol Biol Phys 2010;77:942-949); Krayenbuehl et al. (Int J Radiat Oncol Biol Phys 2010;78:628-634).
    Russi EG; Numico G; Ricardi U
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1279; author reply 1279-80. PubMed ID: 21353165
    [No Abstract]   [Full Text] [Related]  

  • 8. Recent progress in defining mechanisms and potential targets for prevention of normal tissue injury after radiation therapy: In regard to Anscher et al. (Int J Radiat Oncol Biol Phys 2005;62:255-259).
    Sminia P; Mayer R; van der Kleij A; Feldmeier J
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):649-50; author reply 650. PubMed ID: 16168862
    [No Abstract]   [Full Text] [Related]  

  • 9. Erratum to Ringash J, Fisher R, Peters L, et al. Effect of p16 status on the quality-of-life experience during chemoradiation for locally advanced oropharyngeal cancer: a substudy of randomized trial trans-Tasman radiation oncology group (TROG) 02.02 (HeadSTART). Int J Radiat Oncol Biol Phys 2017;97:678-686.
    Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):244. PubMed ID: 28816156
    [No Abstract]   [Full Text] [Related]  

  • 10. In regard to Chen et Al. (Int J Radiat Oncol Biol Phys 2007;69:25-31) and Chao et Al. (Int j Radiat Oncol Biol Phys 2007;69:32-40).
    Yaeger TE
    Int J Radiat Oncol Biol Phys; 2008 May; 71(1):317; author reply 317-8. PubMed ID: 18406902
    [No Abstract]   [Full Text] [Related]  

  • 11. Erratum to: Melidis C, Bosch WR, Izewska J, et al. Global harmonization of quality assurance naming conventions in radiation therapy Clinical Trials. Int J Radiat Oncol Biol Phys 2014;90:1242-1249.
    Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):1115. PubMed ID: 25832708
    [No Abstract]   [Full Text] [Related]  

  • 12. Adjuvant malignant mesothelioma radiotherapy: How many difficulties! In regard to: Allen et al. Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma (Int J Radiat Oncol Biol Phys 2006;65:640-645) and Gupta et al. Hemithoracic radiation therapy after pleurectomy/decortication for malignant pleural mesothelioma (Int J Radiat Oncol Biol Phys 2005;63:1045-1052).
    Russi EG; Pergolizzi S; Lucio F; Ricardi U
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1273-4; author reply 1274. PubMed ID: 17145545
    [No Abstract]   [Full Text] [Related]  

  • 13. Erratum to: Tsang RW, Campbell BA, Goda JS et al. Radiation Therapy for Solitary Plasmacytoma and Multiple Myeloma: Guidelines From the International Lymphoma Radiation Oncology Group. Int J Radiat Oncol Biol Phys 2018;101: 794-808.
    Int J Radiat Oncol Biol Phys; 2018 Dec; 102(5):1602. PubMed ID: 31014797
    [No Abstract]   [Full Text] [Related]  

  • 14. Erratum to: Gunther JR, Jimenez RB, Yechieli RL, et al. Introductory Radiation Oncology Curriculum: Report of a National Needs Assessment and Multi-institutional Pilot Implementation. Int J Radiat Oncol Biol Phys 2018;101:1029-1038.
    Int J Radiat Oncol Biol Phys; 2018 Dec; 102(5):1602. PubMed ID: 31014796
    [No Abstract]   [Full Text] [Related]  

  • 15. Erratum to: Hindley A, Zain Z, Wood L, et al. Mometasone furoate cream reduces acute radiation dermatitis in patients receiving breast radiation therapy: results of a randomized trial. Int J Radiat Oncol Biol Phys 2014;90:748-755.
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(4):882. PubMed ID: 25752410
    [No Abstract]   [Full Text] [Related]  

  • 16. Erratum to: Rodrigues G, Oberije C, Senan S, et al. is intermediate radiation dose escalation with concurrent chemotherapy for stage III non-small cell lung cancer beneficial? A multi-institutional propensity score matched analysis. Int J Radiat Oncol Biol Phys 2015;91:133-139.
    Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):1115. PubMed ID: 25832709
    [No Abstract]   [Full Text] [Related]  

  • 17. Erratum to: Jabbari S, Fitzmaurice T, Munoz F, et al. Cross-Border Collaboration in Oncology: A Model for United States-Mexico Border Health. Int J Radiat Oncol Biol Phys 2015;92:509-511.
    Int J Radiat Oncol Biol Phys; 2015 Oct; 93(2):472. PubMed ID: 26383691
    [No Abstract]   [Full Text] [Related]  

  • 18. Prostate brachytherapy as monotherapy: Are there gaps, holes, and islands in the argument? In regard to Wallner et al. (Int J Radiat Oncol Biol Phys 2003;57:1297-1303).
    Rubenstein J
    Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):305; author reply 305-6. PubMed ID: 15629630
    [No Abstract]   [Full Text] [Related]  

  • 19. In regard to Sperduto et al. (Int j radiat oncol biol phys 2008;70:510-514).
    Weltman E; Brandt RA
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1292; author reply 1292-3. PubMed ID: 18313534
    [No Abstract]   [Full Text] [Related]  

  • 20. Current status and recommendations for the future of research, teaching, and testing in the biological sciences of radiation oncology: report of the American Society for Radiation Oncology Cancer Biology/Radiation Biology Task Force, executive summary.
    Wallner PE; Anscher MS; Barker CA; Bassetti M; Bristow RG; Cha YI; Dicker AP; Formenti SC; Graves EE; Hahn SM; Hei TK; Kimmelman AC; Kirsch DG; Kozak KR; Lawrence TS; Marples B; McBride WH; Mikkelsen RB; Park CC; Weidhaas JB; Zietman AL; Steinberg M
    Int J Radiat Oncol Biol Phys; 2014 Jan; 88(1):11-7. PubMed ID: 24246724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.